Abstract:Due to the occurrence of antibiotic resistance, bacterial infectious diseases have become a serious threat to public health. To overcome antibiotic resistance, novel antibiotics are urgently needed. N-thiadiazole4-hydroxy-2-quinolone-3-carboxamides are a potential new class of antibacterial agents, as one of its derivatives was identified as an antibacterial agent against S. aureus. However, no potency-directed structural optimization has been performed. In this study, we designed and synthesized 37 derivatives, and evaluated their antibacterial activity against S. aureus ATCC29213, which led to the identification of ten potent antibacterial agents with minimum inhibitory concentration (MIC) values below 1 mu g/mL. Next, we performed bacterial growth inhibition assays against a panel of drug-resistant clinical isolates, including methicillin-resistant S. aureus, and cytotoxicity assays with HepG2 and HUVEC cells. One of the tested compounds named 1-ethyl-4-hydroxy-2-oxo-N-(5-(thiazol-2-yl)-1,3,4-thiadiazol-2yl)-1,2-dihydroquinoline-3-carboxamide (g37) showed 2 to 128-times improvement compared with vancomycin in term of antibacterial potency against the tested strains (MICs: 0.25-1 mu g/mL vs. 1-64 14/ mu L) and an optimal selective toxicity (HepG2/MRSA, 110.6 to 221.2; HUVEC/MRSA, 77.6-155.2). Further, comprehensive evaluation indicated that g37 did not induce resistance development of MRSA over 20 passages, and it has been confirmed as a bactericidal, metabolically stable, orally active antibacterial agent. More importantly, we have identified the S. aureus DNA gyrase B as its potential target and proposed a potential binding mode by molecular docking. Taken together, the present work reports the most potent derivative of this chemical series (g37) and uncovers its potential target, which lays a solid foundation for further lead optimization facilitated by the structure-based drug design technique. (C) 2019 Elsevier Masson SAS. All rights reserved.

Design and Synthesis of 2-Hydroxyl-4-methoxyl-3-(3-methylbut-2-en-1-yl)-6-(4-phenylbenzoylamino)benzoic Acid Derivatives As Antibacterial Agents Based on Cajaninstilbene Acid Scaffold Hopping.

Novel cajaninstilbene acid derivatives as antibacterial agents

Cajaninstilbene Acid Derivatives Conjugated with Siderophores of 3-Hydroxypyridin-4(1h)-ones As Novel Antibacterial Agents Against Gram-negative Bacteria Based on the Trojan Horse Strategy

Design, Synthesis and Antimicrobial Evaluation of Novel Benzoxazole Derivatives.

Design and synthesis of unique indole-benzosulfonamide oleanolic acid derivatives as potent antibacterial agents against MRSA

Design, Synthesis and Antibacterial Evaluation of Some New 2-Phenyl-quinoline-4-carboxylic Acid Derivatives

Design, Synthesis and Biological Evaluation of 3-(4-halophenyl)-3-oxopropanal and Their Derivatives As Novel Antibacterial Agents

Novel Benzyl Phenyl Sulfide Derivatives As Antibacterial Agents Against Methicillin-Resistant Staphylococcus Aureus

Design, Synthesis and Evaluation of Hybrid of Tetrahydrocarbazole with 2,4-Diaminopyrimidine Scaffold As Antibacterial Agents.

Synthesis and Biological Evaluation of Halogenated 2-Arylimino-3-arythiazolidine- 4-Ones Containing Benzoic Acid Fragments As Antibacterial Agents

Design, synthesis and biological evaluation of amphiphilic benzopyran derivatives as potent antibacterial agents against multidrug-resistant bacteria

Synthetic Optimization and Antibacterial Activity of Novel Benzodioxepine-Biphenyl Amide Derivatives

Synthesis And Antibacterial Evaluation Of Novel 3-Substituted Ocotillol-Type Derivatives As Leads

Synthesis and antibacterial evaluation of novel 4-alkyl substituted phenyl β-aldehyde ketone derivatives

Design, Synthesis and Antimicrobial Evaluation of Novel Benzimidazole-Incorporated Sulfonamide Analogues

Synthesis and biological evaluation of 5-aryloxypyrazole derivatives bearing a rhodanine-3-aromatic acid as potential antimicrobial agents.

Biological evaluation and chemoproteomics reveal potential antibacterial targets of a cajaninstilbene-acid analogue

Synthesis And Antibacterial Evaluation Of (S,Z)-4-Methyl-2-(4-Oxo-5-((5-Substituted Phenylfuran-2-Yl) Methylene)-2-Thioxothiazolidin-3-Yl) Pentanoic Acids

<i>N</i>-thiadiazole-4-hydroxy-2-quinolone-3-carboxamides bearing heteroaromatic rings as novel antibacterial agents: Design, synthesis, biological evaluation and target identification

Design, Synthesis, Antibacterial Activity, and Mechanisms of Novel Benzofuran Derivatives Containing Disulfide Moieties

Synthesis and Antimicrobial Evaluation of (Z)-5-((3-phenyl-1h-pyrazol-4- Yl)methylene)-2-thioxothiazolidin-4-one Derivatives